These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25608385)

  • 41. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Pincus J
    Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intensive cholesterol lowering therapy to reduce cardiovascular risk].
    Rigotti R A; Arteaga Ll A; Maiz G A
    Rev Med Chil; 2006 May; 134(5):641-8. PubMed ID: 16802058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.
    Blasetto JW; Stein EA; Brown WV; Chitra R; Raza A
    Am J Cardiol; 2003 Mar; 91(5A):3C-10C; discussion 10C. PubMed ID: 12646336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.
    Bertolini S; Bon GB; Campbell LM; Farnier M; Langan J; Mahla G; Pauciullo P; Sirtori C; Egros F; Fayyad R; Nawrocki JW
    Atherosclerosis; 1997 Apr; 130(1-2):191-7. PubMed ID: 9126664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
    Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP;
    Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liptruzet: a combination of ezetimibe and atorvastatin.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
    [No Abstract]   [Full Text] [Related]  

  • 48. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy.
    Le VV; Racine N; Pelletier GB; Carrier M; Cossette M; White M
    Clin Transplant; 2009; 23(2):249-55. PubMed ID: 19402219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study).
    Sasaki J; Otonari T; Sawayama Y; Hata S; Oshima Y; Saikawa T; Biro S; Kono S;
    J Atheroscler Thromb; 2012; 19(5):485-93. PubMed ID: 22659533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
    Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
    Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
    Ballantyne CM; Blazing MA; King TR; Brady WE; Palmisano J
    Am J Cardiol; 2004 Jun; 93(12):1487-94. PubMed ID: 15194018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM; Jones PH; Adamczyk MA; Cain VA; Bryzinski BS; Blasetto JW;
    Curr Med Res Opin; 2003; 19(8):689-98. PubMed ID: 14687438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
    Jones PH; Davidson MH; Stein EA; Bays HE; McKenney JM; Miller E; Cain VA; Blasetto JW;
    Am J Cardiol; 2003 Jul; 92(2):152-60. PubMed ID: 12860216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W
    MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of atorvastatin and atorvastatin-ezetimibe combination therapy on androgen production in hyperandrogenic women with elevated cholesterol levels.
    Krysiak R; Okopien B
    Exp Clin Endocrinol Diabetes; 2015 Feb; 123(2):75-9. PubMed ID: 25350347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
    Davidson MH
    Cleve Clin J Med; 2008 Jul; 75(7):479-82, 486-8, 490-1. PubMed ID: 18646584
    [No Abstract]   [Full Text] [Related]  

  • 59. [A new approach to the treatment of dyslipidemia].
    Kevelaitiene S; Slapikas R
    Medicina (Kaunas); 2008; 44(5):407-13. PubMed ID: 18541958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. If LDL-C is the answer...what was the question? What do the data really show?
    Katholi RE; Deitrick CL; Hardiek KJ
    Heart Dis; 2001; 3(1):2-13. PubMed ID: 11975764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.